Related Experiment Video

Updated: Jul 24, 2026

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation
07:48

Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation

Published on: May 16, 2016

The endotoxin-lipoprotein hypothesis

M Rauchhaus1, A J Coats, S D Anker

  • 1Department of Clinical Cardiology, National Heart and Lung Institute, London, UK. m.rauchhaus@ic.ac.uk

Lancet (London, England)
|October 19, 2000
PubMed

Insights

Statins lower cholesterol but may harm patients with chronic heart failure (CHF). Higher cholesterol might be beneficial in CHF by binding harmful lipopolysaccharides, suggesting non-lipid-lowering statins could be advantageous.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors) revolutionized hypercholesterolemia treatment, reducing cardiovascular disease morbidity and mortality.
  • Simvastatin reduces new-onset heart failure events, but benefits may extend beyond lipid-lowering.
  • Low serum cholesterol is linked to impaired survival in chronic heart failure (CHF) patients, possibly due to inflammation and increased lipopolysaccharide.

Purpose of the Study:

  • To investigate the potential benefits of higher total cholesterol concentrations in CHF patients.
  • To explore the hypothesis that lipoproteins bind lipopolysaccharides, mitigating detrimental effects.
  • To propose that non-lipid-lowering statin properties (immune modulatory, anti-inflammatory) might be beneficial in CHF.

Main Methods:

  • Review of existing evidence on statin effects in cardiovascular disease and CHF.
  • Postulation of a mechanism involving lipoprotein binding of lipopolysaccharides.
  • Hypothesizing an optimal lipoprotein concentration for CHF patients.

Main Results:

  • Evidence suggests lower cholesterol may be detrimental in CHF.
  • Lipoproteins may bind lipopolysaccharides, offering a protective effect.
  • A potential threshold exists below which lipid reduction could be harmful.

Conclusions:

  • Higher total cholesterol concentrations may be beneficial in CHF patients.
  • Lipoprotein's role in binding lipopolysaccharides warrants further investigation.
  • Non-lipid-lowering statins with immune-modulating properties could offer therapeutic advantages in CHF.

More Related Videos

Enrichment of Bacterial Lipoproteins and Preparation of N-terminal Lipopeptides for Structural Determination by Mass Spectrometry10:59

Enrichment of Bacterial Lipoproteins and Preparation of N-terminal Lipopeptides for Structural Determination by Mass Spectrometry

Published on: May 21, 2018

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

Related Concept Videos

Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...
Bacterial Toxins01:12

Bacterial Toxins

Bacterial toxins are sophisticated virulence factors that enable pathogenic bacteria to interact with, invade, and damage host tissues. These toxins fall broadly into two types: protein exotoxins, which are secreted into the environment and target specific host receptors, and lipopolysaccharide endotoxins, which are structural components of the bacterial outer membrane released primarily during bacterial lysis or membrane shedding. Exotoxins generally act more selectively, binding to cell...